Cargando…

Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women

Background: Uterine blood flow determines endometrial thickness. This study examined how vaginal sildenafil citrate and estradiol valerate altered endometrial thickness, blood flow, and fertility in infertile women. Methods: This study observed 148 infertile women whose infertility was unexplained....

Descripción completa

Detalles Bibliográficos
Autores principales: Altyar, Ahmed E., Boshra, Marian S., Abou Warda, Ahmed Essam, Shawkey, Sherwet M., Abdallah Mohamed Salem, Sara, Sarhan, Rania M., Sarhan, Neven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223516/
https://www.ncbi.nlm.nih.gov/pubmed/37241011
http://dx.doi.org/10.3390/jpm13050842
_version_ 1785049960821030912
author Altyar, Ahmed E.
Boshra, Marian S.
Abou Warda, Ahmed Essam
Shawkey, Sherwet M.
Abdallah Mohamed Salem, Sara
Sarhan, Rania M.
Sarhan, Neven
author_facet Altyar, Ahmed E.
Boshra, Marian S.
Abou Warda, Ahmed Essam
Shawkey, Sherwet M.
Abdallah Mohamed Salem, Sara
Sarhan, Rania M.
Sarhan, Neven
author_sort Altyar, Ahmed E.
collection PubMed
description Background: Uterine blood flow determines endometrial thickness. This study examined how vaginal sildenafil citrate and estradiol valerate altered endometrial thickness, blood flow, and fertility in infertile women. Methods: This study observed 148 infertile women whose infertility was unexplained. Group 1 comprised 48 patients who received oral estradiol valerate (Cyclo-Progynova 2 mg/12 h white tablets) from day 6 till ovulation was initiated with clomiphene citrate. A number of 50 participants in group 2 received oral sildenafil (Respatio 20 mg/12 h film-coated tablets) for 5 days starting the day after their previous menstrual period and finishing on the day they ovulated with clomiphene citrate. Group 3 was the control group, with 50 patients receiving clomiphene citrate (Technovula 50 mg/12 h tablets) ovulation induction from the 2nd to 7th day of cycle. All patients had transvaginal ultrasounds to determine ovulation, follicle count, and fertility. Miscarriage, ectopic pregnancy, and multiple pregnancies were monitored for three months. Results: The three groups’ mean ETs differed statistically at p = 0.0004. A statistically significant difference was found between the three groups in terms of the number of follicles, with 69% of patients in group 1 having one and 31% having two or more, 76% of patients in group 2 having one and 24% having two or more, and 90% of patients in the control group having one and 10% having two or more (p = 0.038). The clinical pregnancy rates of the three groups were 58%, 46%, and 27%, respectively (p = 0.005). The distribution of all side effects was not statistically different between the three groups. Conclusion: It is possible to claim that adding oral estrogen to clomiphene citrate therapy as an adjuvant therapy can improve endometrial thickness and, as a result, increase the pregnancy rates in unexplained infertility compared to sildenafil, especially in cases where the infertility has lasted less than two years. Most people who take sildenafil end up with a mild headache.
format Online
Article
Text
id pubmed-10223516
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102235162023-05-28 Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women Altyar, Ahmed E. Boshra, Marian S. Abou Warda, Ahmed Essam Shawkey, Sherwet M. Abdallah Mohamed Salem, Sara Sarhan, Rania M. Sarhan, Neven J Pers Med Article Background: Uterine blood flow determines endometrial thickness. This study examined how vaginal sildenafil citrate and estradiol valerate altered endometrial thickness, blood flow, and fertility in infertile women. Methods: This study observed 148 infertile women whose infertility was unexplained. Group 1 comprised 48 patients who received oral estradiol valerate (Cyclo-Progynova 2 mg/12 h white tablets) from day 6 till ovulation was initiated with clomiphene citrate. A number of 50 participants in group 2 received oral sildenafil (Respatio 20 mg/12 h film-coated tablets) for 5 days starting the day after their previous menstrual period and finishing on the day they ovulated with clomiphene citrate. Group 3 was the control group, with 50 patients receiving clomiphene citrate (Technovula 50 mg/12 h tablets) ovulation induction from the 2nd to 7th day of cycle. All patients had transvaginal ultrasounds to determine ovulation, follicle count, and fertility. Miscarriage, ectopic pregnancy, and multiple pregnancies were monitored for three months. Results: The three groups’ mean ETs differed statistically at p = 0.0004. A statistically significant difference was found between the three groups in terms of the number of follicles, with 69% of patients in group 1 having one and 31% having two or more, 76% of patients in group 2 having one and 24% having two or more, and 90% of patients in the control group having one and 10% having two or more (p = 0.038). The clinical pregnancy rates of the three groups were 58%, 46%, and 27%, respectively (p = 0.005). The distribution of all side effects was not statistically different between the three groups. Conclusion: It is possible to claim that adding oral estrogen to clomiphene citrate therapy as an adjuvant therapy can improve endometrial thickness and, as a result, increase the pregnancy rates in unexplained infertility compared to sildenafil, especially in cases where the infertility has lasted less than two years. Most people who take sildenafil end up with a mild headache. MDPI 2023-05-17 /pmc/articles/PMC10223516/ /pubmed/37241011 http://dx.doi.org/10.3390/jpm13050842 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Altyar, Ahmed E.
Boshra, Marian S.
Abou Warda, Ahmed Essam
Shawkey, Sherwet M.
Abdallah Mohamed Salem, Sara
Sarhan, Rania M.
Sarhan, Neven
Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title_full Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title_fullStr Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title_full_unstemmed Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title_short Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women
title_sort comparative evaluation of sildenafil citrate and estrogen as an adjuvant therapy for treatment of unexplained infertility in women
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223516/
https://www.ncbi.nlm.nih.gov/pubmed/37241011
http://dx.doi.org/10.3390/jpm13050842
work_keys_str_mv AT altyarahmede comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT boshramarians comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT abouwardaahmedessam comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT shawkeysherwetm comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT abdallahmohamedsalemsara comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT sarhanraniam comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen
AT sarhanneven comparativeevaluationofsildenafilcitrateandestrogenasanadjuvanttherapyfortreatmentofunexplainedinfertilityinwomen